Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Fidelity

FullerThaler Behavioral Small-Cap Equity Fund Institutional Shares (FTHSX)

Ticker FTHSX · Since 2011-09-08 · · Holdings as of Jun 30, 2026

Expense ratio
0.76%$76/yr per $10k
5-yr return
+14.1%annualized
1-yr return
+12.0%as of Dec 2025
Net assets
$12.7Ball share classes
Holdings
121

Bottom line

Is FTHSX a good fund? The bottom line

FTHSX is the Institutional share class of FullerThaler Behavioral Small-Cap Equity Fund, an actively managed small-cap mutual fund from Fidelity.

It charges 0.76% — about $76 a year on every $10,000 invested, cheaper than 78% of small-cap funds we track.

It returned +12.0% over one year, +14.1% a year over five years, +13.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $12.7 billion in net assets and 121 holdings, its largest position is Exelixis Inc (3.0%) and the top 10 make up 23.3% of the portfolio.

What stands out

  • Low cost: cheaper than 78% of small-cap peers
  • 5-year return beat 98% of category peers
  • No front-end sales load
  • Large and established ($12.7 billion)

Updated Nov 19, 2026

What FTHSX invests in

The FullerThaler Behavioral Small-Cap Equity Fund (the ?Small-Cap Equity Fund? or the ?Fund?) seeks long-term capital appreciation.

Under normal circumstances, the Fund seeks to achieve its objective by investing at least 80% of its net assets (plus borrowings for investment purposes) in common stocks of small capitalization (?small-cap?) companies based in the U.S. (?80% Policy?). The Fund must provide shareholders with 60 days? prior written notice if it changes its 80% Policy. The Fund considers a company to be based in the U.S. if it is publicly traded in the U.S. and it satisfies one or more of the following additional criteria: it is incorporated in the U.S., it is headquartered in the U.S., its reported assets are primarily located in the U.S., or it derives the majority of its revenue from the U.S. The Fund defines small-cap companies as companies whose market capitalizations are generally in the lowest 10% of total market capitalization or companies whose market capitalizations are smaller than or equal to…

From the fund's prospectus (filed Feb 2, 2026).

FTHSX performance

Fund calendar-year total returns, 2016–2025 2016: +29.8%; 2017: +17.3%; 2018: −13.2%; 2019: +28.1%; 2020: +10.4%; 2021: +30.8%; 2022: −7.5%; 2023: +22.6%; 2024: +16.3%; 2025: +12.0% +30% 2016 +17% 2017 −13% 2018 +28% 2019 +10% 2020 +31% 2021 −7% 2022 +23% 2023 +16% 2024 +12% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FTHSX+12.0%+14.1%+13.7%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full FTHSX performance history →

What FTHSX costs

On a $10,000 investment, FTHSX's 0.76% expense ratio costs about $76 a year. The prospectus estimates $942 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full FTHSX fee table →

FTHSX top 10 holdings

#Holding% of fund
1Exelixis Inc3.03%
2Jazz Pharmaceuticals Plc2.97%
3Emcor Group Inc2.70%
4Match Group Inc2.42%
5Applied Industrial Technologies Inc2.28%
6Affiliated Managers Group Inc2.18%
7Acuity Inc2.05%
8Garrett Motion Inc2.00%
9Encompass Health Corp1.87%
10Borgwarner Inc1.84%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 23.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to FTHSX

More funds like FTHSX →

FTHSX FAQ

What is the expense ratio of FTHSX?
FTHSX's expense ratio is 0.76%, which works out to about $76 a year for every $10,000 invested. The prospectus estimates total costs of $942 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FTHSX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 78% of small-cap peers; 5-year return beat 98% of category peers; no front-end sales load; large and established ($12.7 billion). This is general information, not personalized advice.
What does FTHSX hold?
FTHSX's largest holdings are Exelixis Inc (3.0%), Jazz Pharmaceuticals Plc (3.0%), Emcor Group Inc (2.7%), Match Group Inc (2.4%), Applied Industrial Technologies Inc (2.3%). It holds 121 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is FTHSX's 5-year return?
FTHSX returned +14.1% a year over the five years ending Dec 31, 2025, and +13.7% a year over ten years. Past performance does not guarantee future results.
Does FTHSX have a sales load?
No. FTHSX has no front-end sales charge.
Who manages FTHSX?
FTHSX is offered by Fidelity through Capitol Series Trust.